Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
Fiche publication
Date publication
mai 2024
Journal
PloS one
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CONROY Thierry
Tous les auteurs :
Zhou K, Robert M, Seegers V, Blanc-Lapierre A, Savouroux S, Bigot F, Frenel JS, Campone M, Conroy T, Penault-Llorca F, Raoul JL, Bellanger MM
Lien Pubmed
Résumé
Longer times between diagnosis and treatments of cancer patients have been estimated as effects of the COVID-19 pandemic. However, relatively few studies attempted to estimate actual delay to treatment at the patient level.
Mots clés
Humans, COVID-19, epidemiology, Female, Breast Neoplasms, therapy, Middle Aged, Time-to-Treatment, statistics & numerical data, Aged, France, epidemiology, Adult, Pandemics, SARS-CoV-2, isolation & purification, Cohort Studies
Référence
PLoS One. 2024 05 31;19(5):e0304556